Continuing or adding IL-2 in patients treated with antiretroviral therapy (ACTG Protocol A5051, a rollover trial of ACTG Protocol A328)

Ronald J. Bosch, Richard B Pollard, Alan Landay, Evgenia Aga, Lawrence Fox, Ronald Mitsuyasu

Research output: Contribution to journalArticle

4 Scopus citations

Fingerprint Dive into the research topics of 'Continuing or adding IL-2 in patients treated with antiretroviral therapy (ACTG Protocol A5051, a rollover trial of ACTG Protocol A328)'. Together they form a unique fingerprint.

Medicine & Life Sciences